TAS3351

· Taiho Oncology, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TAS3351, covering 2026-04-02 to 2026-04-02. Get the full timeline:

Most recent: Clinical Trial Update: A Study of TAS3351 in NSCLC Patients With EGFRmt [Phase 1]